Checkpoint kinase1 (CHEK1), one of the DNA-damage checkpoint proteins, was reported reducing the stem cell population in ovarian cancer, triggered by its inhibitor (LY2603618) [46]. This evidence concerns the gene CHEK1 and ovarian cancer.